{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:53:02Z","timestamp":1789645982760,"version":"4.0.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>This study evaluated the <jats:italic>in vitro<\/jats:italic> effectiveness of anti-cryptosporidial agents nitazoxanide, halofuginone, the pyrazolopyridine analog KDU731, and paromomycin (PMC) in combating the significant zoonotic pathogen <jats:italic>Cryptosporidium parvum<\/jats:italic>. The study utilized HCT-8 host cells to culture <jats:italic>C. parvum<\/jats:italic> and fluorescent microscopy\/quantitative PCR (qPCR) for detecting parasitic growth. The efficacy of the compounds was assessed by calculating their inhibitory concentrations (IC) against the total growth of <jats:italic>C. parvum<\/jats:italic> at 48\u2009h post-infection. The study further investigated the impact of these compounds on early parasitophorous vacuole (PV) formation, merozoite egress, host cell viability, and cell growth cycle. KDU731 displayed the most promising profile, with low nanomolar (102\u2009nM\u2009\u00b1\u20092.28) activity and negligible host cell toxicity. This study offers new insights into the relative efficacy and safety of various anti-cryptosporidial compounds, highlighting their stage-specific effects on <jats:italic>C. parvum<\/jats:italic> and the consequential impacts on host cells. Identifying safe and effective anti-cryptosporidial agents contributes significantly to the One Health approach, which emphasizes the importance of integrated strategies in controlling zoonotic diseases.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1463457","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:43:07Z","timestamp":1728016987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative efficacy and safety of anti-cryptosporidial agents: an in vitro study on nitazoxanide, halofuginone lactate, KDU731, and paromomycin against Cryptosporidium parvum"],"prefix":"10.3389","volume":"15","author":[{"given":"Saffron T. G.","family":"Whitta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Lamont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossarin","family":"Suwanarusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morad-R\u00e9my","family":"Muhsin-Sharafaldine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2334-9-195","article-title":"High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial","volume":"9","author":"Amadi","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"ref3","article-title":"Intestinal cryptosporidiosis at an early age and its negative consequences","author":"Be\u01d0er","year":"2006","journal-title":"Med. Parazitol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1358\/dot.2021.57.7.3235211","article-title":"Role of nitazoxanide as a repurposed drug in the treatment and management of various diseases","volume":"57","author":"Bharti","year":"2021","journal-title":"Drugs Today"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14787210.2023.2160704","article-title":"Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better","volume":"21","author":"Caravedo","year":"2023","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/microorganisms8060879","article-title":"Changes in the microbiome of cryptosporidium-infected mice correlate to differences in susceptibility and infection levels","volume":"8","author":"Charania","year":"2020","journal-title":"Microorganisms"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2019.18691","article-title":"Cryptosporidiosis","volume":"323","author":"Desai","year":"2020","journal-title":"JAMA"},{"key":"ref8","volume-title":"Halocur, INN-Halofuginone (as lactate salt) \u2013 summary of the European public assessment report","year":"2004"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1016\/j.drudis.2022.05.020","article-title":"Prospects of halofuginone as an antiprotozoal drug scaffold","volume":"27","author":"Gill","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.chom.2021.07.002","article-title":"Cryptosporidium rhoptry effector protein ROP1 injected during invasion targets the host cytoskeletal modulator LMO7","volume":"29","author":"Gu\u00e9rin","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4269\/ajtmh.1999.61.707","article-title":"Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in apoor urban community in Northeast Brazil","volume":"61","author":"Guerrant","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref12","first-page":"31","article-title":"A comparison of economic losses due to calf enteritis and calf pneumonia in northern Scotland","author":"Gunn","year":"1997","journal-title":"Epidemiol. Sante Anim."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/19490976.2015.1062959","article-title":"Dynamic changes of the luminal and mucosaassociated gut microbiota during and after antibiotic therapy with paromomycin","volume":"6","author":"Heinsen","year":"2015","journal-title":"Gut Microbes"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.pt.2019.12.016","article-title":"A one health approach to tackle cryptosporidiosis","volume":"36","author":"Innes","year":"2020","journal-title":"Trends Parasitol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.vetpar.2016.08.003","article-title":"Greater intensity and frequency of Cryptosporidium and Giardia oocyst shedding beyond the neonatal period is associated with reductions in growth, carcase weight and dressing efficiency in sheep","volume":"228","author":"Jacobson","year":"2016","journal-title":"Vet. Parasitol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3168\/jds.S0022-0302(05)72854-X","article-title":"Effect of halofuginone lactate on the occurrence of Cryptosporidium parvum and growth of neonatal dairy calves","volume":"88","author":"Jarvie","year":"2005","journal-title":"J. Dairy Sci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/s41467-019-09880-w","article-title":"A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors","volume":"10","author":"Jumani","year":"2019","journal-title":"Nat. Commun."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.1016\/S2214-109X(18)30283-3","article-title":"Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study","volume":"6","author":"Khalil","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"102788","DOI":"10.1016\/j.parint.2023.102788","article-title":"Dientamoeba fragilis associated with microbiome diversity changes in acute gastroenteritis patients","volume":"97","author":"Muhsin-Sharafaldine","year":"2023","journal-title":"Parasitol. Int."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0304-4017(93)90075-X","article-title":"The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves","volume":"45","author":"Naciri","year":"1993","journal-title":"Vet. Parasitol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prevetmed.2009.05.003","article-title":"Systematic review and meta-analyses of the effects of halofuginone against calf cryptosporidiosis","volume":"91","author":"Silverl\u00e5s","year":"2009","journal-title":"Prev. Vet. Med."},{"key":"ref23","article-title":"Cryptosporidiosis: still a problem","volume":"17","author":"Smith","year":"2007","journal-title":"AIDS Reader"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.vetpar.2011.05.050","article-title":"Cryptosporidium and Giardia associated with reduced lamb carcase productivity","volume":"182","author":"Sweeny","year":"2011","journal-title":"Vet. Parasitol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1038\/s41564-019-0539-x","article-title":"Life cycle progression and sexual development of the apicomplexan parasite Cryptosporidium parvum","volume":"4","author":"Tandel","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1128\/aac.42.8.1959","article-title":"Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models","volume":"42","author":"Theodos","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/vr.d1492","article-title":"Papers: efficacy of halofuginone lactate in the prevention of cryptosporidiosis in dairy calves","volume":"168","author":"Trotz-Williams","year":"2011","journal-title":"Vet. Rec."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00281-020-00779-z","article-title":"The clever strategies used by intracellular parasites to hijack host gene expression","volume":"42","author":"Villares","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/14787210.2.1.43","article-title":"Nitazoxanide: a new broad spectrum antiparasitic agent","volume":"2","author":"White","year":"2004","journal-title":"Expert Rev. Anti-Infect. Ther."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1463457\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:43:11Z","timestamp":1728016991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1463457\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":29,"alternative-id":["10.3389\/fmicb.2024.1463457"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1463457","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"article-number":"1463457"}}